Le Lézard
Classified in: Health
Subject: RCL

Food Recall Warning - Certain Circle K / Couche Tard brand Sandwiches recalled due to Listeria monocytogenes


Product photos are available: https://recalls-rappels.canada.ca/en/alert-recall/food-recall-warning-certain-circle-k-couche-tard-brand-sandwiches-recalled-due

OTTAWA, ON, Oct. 14, 2022 /CNW/ -

Summary
Affected products

Brand

Product

Size

UPC                        

Codes              

Circle K /
Couche Tard     

Egg Salad

170 g     

8 74111 00963 0

Best Before:

22-OC-12

22-OC-13

22-OC-14

Circle K /
Couche Tard

Mexican Chicken Wrap

334 g

8 74111 00954 8

Best Before:

22-OC-12

22-OC-13

22-OC-14

Circle K /
Couche Tard

Chicken Caesar Pita with
Bacon

319 g

8 74111 00953 1

Best Before:

22-OC-12

22-OC-13

22-OC-14

Circle K /
Couche Tard

Pizza Submarine

225 g

8 74111 00960 9

Best Before:

22-OC-12

22-OC-13

22-OC-14

Circle K /
Couche Tard

Ham and Swiss Cheese
Croissant

184 g

8 74111 00959 3

Best Before:

22-OC-12

22-OC-13

22-OC-14

Circle K /
Couche Tard

Chicken Salad Club

255 g

8 74111 00969 2

Best Before:

22-OC-12

22-OC-13

22-OC-14

Circle K /
Couche Tard

Ham Salad Club

265 g

8 74111 00970 8

Best Before:

22-OC-12

22-OC-13

22-OC-14

Circle K /
Couche Tard

Chicken Caesar Salad with
Bacon

261 g

8 74111 00966 1

Best Before:

22-OC-12

22-OC-13

22-OC-14

Circle K /
Couche Tard

Three Meats Submarine

229 g

8 74111 00974 6

Best Before:

22-OC-12

22-OC-13

22-OC-14

Circle K /
Couche Tard

South-Western Steak
Submarine

234 g

8 74111 00973 9

Best Before:

22-OC-12

22-OC-13

22-OC-14

Circle K /
Couche Tard

Bacon Breakfast Sandwich

120 g

8 74111 00978 4

Best Before:

22-OC-12

22-OC-13

22-OC-14

Circle K /
Couche Tard

Sausage Breakfast Sandwich     

164 g

8 74111 00977 7

Best Before:

22-OC-12

22-OC-13

22-OC-14

Circle K /
Couche Tard

Bourbon Beef Wrap

310 g

8 74111 00979 1

Best Before:

22-OC-12

22-OC-13

22-OC-14

Circle K /
Couche Tard

BLD Club Wrap

306 g

8 74111 00980 7

Best Before:

22-OC-12

22-OC-13

22-OC-14

Issue

The affected products are being recalled from the marketplace due to possible Listeria monocytogenes contamination.

The recalled products have been sold in Quebec and may have been distributed in other provinces and territories.

What you should do

Food contaminated with Listeria monocytogenes may not look or smell spoiled but can still make you sick. Symptoms can include vomiting, nausea, persistent fever, muscle aches, severe headache and neck stiffness. Pregnant women, the elderly and people with weakened immune systems are particularly at risk. Although infected pregnant women may experience only mild, flu-like symptoms, the infection can lead to premature delivery, infection of the newborn or even stillbirth. In severe cases of illness, people may die.

Learn more:

Background

This recall was triggered by the company.

There have been no reported illnesses associated with the consumption of these products.

What is being done

The Canadian Food Inspection Agency (CFIA) is conducting a food safety investigation, which may lead to the recall of other products.

The CFIA is verifying that industry is removing recalled products from the marketplace.

SOURCE Canadian Food Inspection Agency (CFIA)


These press releases may also interest you

at 03:20
Calliditas Therapeutics AB (STO: CALTX) ("Calliditas") today announces that its partner Viatris Pharmaceutical Japan G.K. ("Viatris") has initiated a phase III clinical trial in Japan with Nefecon, named VR-205 in the Japanese market, in Japanese...

at 03:00
Global biotechnology leader CSL Behring today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the...

at 02:30
SOPHiA GENETICS , a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that Dhiti Omics Technologies, a precision molecular diagnostics service provider in India, is live on the SOPHiA...

at 01:15
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...

at 01:05
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...

3 jui 2024
YOUR LEGAL RIGHTS MAY BE AFFECTED There is a proposed settlement in a class-action lawsuit filed against Pfizer Inc., Pfizer Ireland Pharmaceuticals, Warner-Lambert Company, and Warner-Lambert Company LLC (collectively, "Pfizer") and Ranbaxy Inc.,...



News published on and distributed by: